Altium Capital Management LP Legend Biotech Corp Put Options Transaction History
Altium Capital Management LP
- $283 Million
- Q3 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding LEGN
# of Institutions
227Shares Held
76.3MCall Options Held
199KPut Options Held
342K-
Price T Rowe Associates Inc Baltimore, MD11.2MShares$399 Million0.06% of portfolio
-
Ra Capital Management, L.P. Boston, MA7.51MShares$268 Million5.1% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E96.64MShares$237 Million7.41% of portfolio
-
Black Rock Inc. New York, NY5.72MShares$204 Million0.01% of portfolio
-
Westfield Capital Management CO LP Boston, MA5.71MShares$204 Million0.86% of portfolio
About Legend Biotech Corp
- Ticker LEGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 167,403,008
- Market Cap $5.98B
- Description
- Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...